A Phase 2 interventional study of Autologous adipose-derived MSCs and Compound betamethasone in Rotator Cuff Tear and Lateral Epicondylitis, sponsored by Second Affiliated Hospital, School of Medicine, Zhejiang University. Status unknown at 1 site in China. Open to participants aged 18 Years to 90 Years. Per ClinicalTrials.gov, last updated 2018-04-26.
Sponsored by Second Affiliated Hospital, School of Medicine, Zhejiang University · Phase 2, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 27 studies in Rotator Cuff Injuries with a site in China — 13 open to participants now, 13 under way, 1 of them phase 3. Rotator Cuff Injuries · China.
Among the 27 studies in Rotator Cuff Injuries with a site in China, this one is the 2nd largest by planned enrollment of the 18 interventional ones that give a count, is one of 3 that started in 2018, is one of 2 in phase 2, and was the 1st registered.
631 studies on the registry are indexed under Rotator Cuff Injuries; 156 are open to participants now.
Browse Rotator Cuff Injuries studies →13 of the 27 studies in Rotator Cuff Injuries with a site in China are open now. Recruiting first, the newest first:
Second Affiliated Hospital, School of Medicine, Zhejiang University · Sites in China
Ages 8–80
Peking University Third Hospital · Sites in China
Ages 18+
Second Affiliated Hospital of Nanchang University · Sites in China
Ages 18–70
Weiliang Shen, Ph.D., M.D. · Sites in China
Ages 50–75
Peking University Third Hospital · Sites in China
A study can be open while its sites in China have not opened yet or have stopped. Only those recruiting at a site in China →
Of the 100 Rotator Cuff Injuries studies recruiting now, 40 (40%) set no upper age limit and 41 (41%) stop at 75 or younger; 9 take children under 18; 10 take healthy volunteers.
This study: 18 Years to 90 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
27 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 2 3 · Phase 3 1
First in 2012; this study’s year is marked. 3 started in 2018.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 200 is above the median of 60 across 456 interventional studies indexed under Rotator Cuff Injuries.
Median enrollment 59 across the 18 interventional studies, 134 across the 9 observational. Of the 10 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 27 has an industry lead sponsor. The 10 most frequent:
Second Affiliated Hospital, School of Medicine, Zhejiang University is the lead sponsor of 1,043 studies on the registry; 499 are open to participants now.
Second Affiliated Hospital, School of Medicine, Zhejiang University has 6 studies filed under Rotator Cuff Injuries — fewer than ten, so there is no comparison to draw.
3 of the studies in Rotator Cuff Injuries with a site in China that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07714473Hua LuoEvaluation of the Therapeutic Effect of Local Application of Tranexamic Acid in Rotator Cuff Repair | 2026-11-30 |
| NCT06431191Beijing Jishuitan HospitalDoes Medial Raw Anchor Necessary During Tendon Repair Combined With Microfracture | 2026-12-31 |
| NCT07348016Second Affiliated Hospital of Nanchang UniversitySafety and Efficacy of Platelet-Rich Plasma Combined With Compound Betamethasone in Arthroscopic Surgery for Rotator Cuff Injury With Shoulder Adhesion: A Prospective, Multicenter, Randomized Controlled Trial | 2027-07-30 |
Add all 3 to your calendar (.ics) → With an account.
Among the 27 studies in Rotator Cuff Injuries with a site in China, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
This study was a single-center, randomized, single-blind clinical trial. We plan to include 100 patients who met exclusion criteria of rotator cuff and lateral epicondylosis (tennis elbow) respectively by MRT or ultrasonography. The patients will be randomly divided into two groups. Adipose mesenchymal stem cells will be isolated from adipose tissue, cultured and then transplanted back to the tendon injury site by multiple point injection. 1*10\^6 cells as an unit. Patients in the experiment group will be injected into an unit of adipose mesenchymal stem cells (1*10\^6/10kg) while the control group received the same dose compound betamethasone injection. Follow up visit for all patients will occur at 1,3,6 and 12 months after the first injection. Clinical quantitative assessment will measure by the visual analogue scale(VAS). The secondary outcomes are the constant-murley score(CMS) and the rating scale of the American shoulder and elbow surgeons(ASES) and the disability of arm shoulder and hand(DASH). The objective evaluation methods is that the examination of MRI or ultrasound were accomplished before the first injection and at 6 and 12 months afterwards.
All injection will be done under ultrasound guidance.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The dose of adipose-derived mesenchymal stem cells was related to body weight, and 1 × 10 \^ 6 cells were a unit. One unit of adipose-derived mesenchymal stem cells was injected every 10 kg of body weight and injected once a week for three times.
Biological: Autologous adipose-derived MSCs
1ml dexamethasone mixed with 0.5-2ml of saline to achieve the same injection volume with the cell suspension (which contains betamethasone dipropionate 5mg and betamethasone sodium phosphate 2mg) ), once a week for three times.
Drug: Compound betamethasone
The dose of adipose-derived mesenchymal stem cells was related to body weight, and 1 × 10 \^ 6 cells were a unit. One unit of adipose-derived mesenchymal stem cells was injected every 10 kg of body weight and injected once a week for three times.
Drug pages: Betamethasone sodium phosphate · Betamethasone dipropionate
1ml dexamethasone mixed with 0.5-2ml of saline to achieve the same injection volume with the cell suspension (which contains betamethasone dipropionate 5mg and betamethasone sodium phosphate 2mg) ), once a week for three times.
Change from baseline in Visual Analog Scale(VAS) at 3, 6 and 12 weeks
Pain on activity will be evaluated by VAS
Time frame: Baseline, 3 weeks, 6 weeks, 12 weeks after intervention
Change from baseline in Constant-Murley Score(CMS) at 3, 6 and 12 weeks,
Functional score of the shoulder
Time frame: Baseline, 3 weeks, 6 weeks, 12 weeks after intervention
American Shoulder and Elbow Surgeons (ASES) Shoulder Score
Functional score of the shoulder
Time frame: Baseline, 3 weeks, 6 weeks, 12 weeks after intervention
The Disabilities of the Arm, Shoulder and Hand(DASH) Score
Functional score of the shoulder
Time frame: Baseline, 3 weeks, 6 weeks, 12 weeks after intervention
Adverse events
Adverse events to evaluate the safety
Time frame: From baseline through study completion, an average of 1 year
Plan to share: No
Start is estimated for Oct 2018; primary completion for Dec 2019, 14 months later.
How these figures are worked out, and which studies are left out of them.
This study is status unknown, as verified in Aug 2017. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Second Affiliated Hospital, School of Medicine, Zhejiang University →